Search research articles
Contact Us
Filters
Showing results (181-190 of 304) with videos related to
Page
of 31
Sort By:
American Journal of Hypertension
|
January 2, 2010
Decreased NKCC1 activity in erythrocytes from African Americans with hypertension and dyslipidemia
Sergei N Orlov, Francis Gossard, Zdenka Pausova, et al.
Nature Medicine
|
June 18, 2013
A largely random AAV integration profile after LPLD gene therapy
Christine Kaeppel, Stuart G Beattie, Raffaele Fronza, et al.
Clinical Epigenetics
|
June 25, 2016
PPARGC1α gene DNA methylation variations in human placenta mediate the link between maternal hyperglycemia and leptin levels in newborns
Sandra Côté, Valérie Gagné-Ouellet, Simon-Pierre Guay, et al.
Diabetes
|
February 28, 2007
Association studies of BMI and type 2 diabetes in the neuropeptide Y pathway: a possible role for NPY2R as a candidate gene for type 2 diabetes in men
Catarina D Campbell, Helen N Lyon, James Nemesh, et al.
Nature Medicine
|
June 6, 2014
Reply to: NGS library preparation may generate artifactual integration sites of AAV vectors
Christine Kaeppel, Stuart G Beattie, Raffaele Fronza, et al.
The New England Journal of Medicine
|
September 3, 2024
Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk
Gerald F Watts, Robert S Rosenson, Robert A Hegele, et al.
Atherosclerosis
|
March 8, 2025
The vicious circle of chronic kidney disease and hypertriglyceridemia: What is first, the hen or the egg?
Daniele Tramontano, Laura D'Erasmo, Miriam Larouche, et al.
Journal of Clinical Lipidology
|
April 2, 2024
Corrigendum to "Volanesorsen and triglyceride levels in familial chylomicronemia syndrome: Long-term efficacy and safety data from patients in an open-label extension trial" [Journal of Clinical Lipidology, Volume 17, Issue 3, May-June 2023, Pages 342-355]
Joseph L Witztum, Daniel Gaudet, Marcello Arca, et al.
CJC Open
|
March 12, 2020
Prediction of Familial Hypercholesterolemia in Patients at High Atherosclerotic Cardiovascular Disease Risk Using a Recently Validated Algorithm
Latifah Alothman, Magdaline Zawadka, Sumayah Aljenedil, et al.
Circulation
|
November 16, 2024
Temporal Effects of Plozasiran on Lipids and Lipoproteins in Persistent Chylomicronemia
Gerald F Watts, Robert A Hegele, Robert S Rosenson, et al.
Page
of 31
Search research articles
Search
Showing results (181-190 of 304) with videos related to
Sort By:
Page
of 31
American Journal of Hypertension
|
January 2, 2010
Decreased NKCC1 activity in erythrocytes from African Americans with hypertension and dyslipidemia
Sergei N Orlov, Francis Gossard, Zdenka Pausova, et al.
Nature Medicine
|
June 18, 2013
A largely random AAV integration profile after LPLD gene therapy
Christine Kaeppel, Stuart G Beattie, Raffaele Fronza, et al.
Clinical Epigenetics
|
June 25, 2016
PPARGC1α gene DNA methylation variations in human placenta mediate the link between maternal hyperglycemia and leptin levels in newborns
Sandra Côté, Valérie Gagné-Ouellet, Simon-Pierre Guay, et al.
Diabetes
|
February 28, 2007
Association studies of BMI and type 2 diabetes in the neuropeptide Y pathway: a possible role for NPY2R as a candidate gene for type 2 diabetes in men
Catarina D Campbell, Helen N Lyon, James Nemesh, et al.
Nature Medicine
|
June 6, 2014
Reply to: NGS library preparation may generate artifactual integration sites of AAV vectors
Christine Kaeppel, Stuart G Beattie, Raffaele Fronza, et al.
The New England Journal of Medicine
|
September 3, 2024
Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk
Gerald F Watts, Robert S Rosenson, Robert A Hegele, et al.
Atherosclerosis
|
March 8, 2025
The vicious circle of chronic kidney disease and hypertriglyceridemia: What is first, the hen or the egg?
Daniele Tramontano, Laura D'Erasmo, Miriam Larouche, et al.
Journal of Clinical Lipidology
|
April 2, 2024
Corrigendum to "Volanesorsen and triglyceride levels in familial chylomicronemia syndrome: Long-term efficacy and safety data from patients in an open-label extension trial" [Journal of Clinical Lipidology, Volume 17, Issue 3, May-June 2023, Pages 342-355]
Joseph L Witztum, Daniel Gaudet, Marcello Arca, et al.
CJC Open
|
March 12, 2020
Prediction of Familial Hypercholesterolemia in Patients at High Atherosclerotic Cardiovascular Disease Risk Using a Recently Validated Algorithm
Latifah Alothman, Magdaline Zawadka, Sumayah Aljenedil, et al.
Circulation
|
November 16, 2024
Temporal Effects of Plozasiran on Lipids and Lipoproteins in Persistent Chylomicronemia
Gerald F Watts, Robert A Hegele, Robert S Rosenson, et al.
Page
of 31